PDL BIOPHARMA, INC.'s Net Worth

-$30.1 Million

Estimate Recalculated May 9, 2024 03:36PM EST

Who is PDL BIOPHARMA, INC.?

PDL BIOPHARMA, INC. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include LENSAR, Inc., and Evofem Biosciences, Inc..

SEC CIK

PDL BIOPHARMA, INC.'s CIK is 0000882104

Past Insider Trading and Trends

2019 was PDL BIOPHARMA, INC.'s most active year for acquiring shares with 2 total transactions. PDL BIOPHARMA, INC.'s most active month to acquire stocks was the month of May. 2020 was PDL BIOPHARMA, INC.'s most active year for disposing of shares, totalling 2 transactions. PDL BIOPHARMA, INC.'s most active month to dispose stocks was the month of April. 2019 saw PDL BIOPHARMA, INC. paying a total of $30,000,001.50 for 8,333,334 shares, this is the most they've acquired in one year. In 2020 PDL BIOPHARMA, INC. cashed out on 22,000,731 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LENSAR, Inc. (LNSR) Snapshot price: $3.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.66M
$11.16
$97,125.48
0
Sep 29 - Oct 1
Form 3
—
0
—
—
0
No matching records found

Evofem Biosciences, Inc. (EVFM) Snapshot price: $0.0314

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-13.33M
—
—
0
May 21
Form 4
+100.00%
6.67M
$4.50
$30,000,001.50
13.33M
Jun 10
Form 3
—
0
—
—
0
No matching records found